Business Context and Reporting Period
VPC Impact Acquisition Holdings (“VIH”), a Cayman Islands special purpose acquisition company, filed this Form 8-K on April 1, 2021. The filing concerns VIH’s proposed business combination with Bakkt Holdings, LLC (“Bakkt”), which is expected to result in a combined public company. The filing is not a Bakkt operating or periodic financial report.
Transaction Update
VIH announced that it filed a registration statement on Form S-4 with the SEC. The S-4 includes a preliminary proxy statement and prospectus relating to the proposed transaction, shareholder approval process, and securities expected to be issued in connection with the transaction and related domestication.
The definitive proxy statement/prospectus will be distributed to VIH shareholders after the registration statement is declared effective. The filing states that the preliminary materials are not a substitute for the definitive documents and should not alone form the basis of an investment decision.
Financial Metrics and Material Changes
The filing does not provide current-period revenue, profit, cash flow, margins, debt, liquidity, operating results, or other clear financial metrics for Bakkt or VIH. It also does not provide a clear comparison with a prior comparable period or identify material changes in operating performance.
The filing references estimated future results, implied enterprise value, transaction structure, ownership structure, and other projections, but states that annualized, pro forma, projected, and estimated figures are illustrative and may not reflect actual results.
Guidance, Outlook, Risks, and Contingencies
- Completion of the transaction remains subject to customary closing conditions, including approval by VIH shareholders and Bakkt members.
- Closing may be affected by shareholder redemptions, including any failure to meet the minimum cash condition, and by Nasdaq listing requirements.
- Other risks include transaction costs, delays in realizing expected benefits, management distraction, the COVID-19 pandemic, competitive and technology changes, regulatory developments, market conditions, execution of growth and acquisition strategies, data security, and internal-control effectiveness.
- Forward-looking statements regarding Bakkt’s market opportunity, future results, operating plans, and the transaction are subject to significant uncertainties and may differ materially from actual outcomes.
- The filing contains no binding operating guidance or clear financial forecast that can be treated as reported guidance.
Important Facts for Investors to Verify
- Review the Form S-4 and subsequent amendments, including the definitive proxy statement/prospectus, for transaction terms, valuation, ownership, dilution, projections, and audited financial statements.
- Verify whether VIH and Bakkt obtain all required shareholder, member, regulatory, exchange-listing, and other approvals.
- Assess the effect of shareholder redemptions and the resulting cash available to the combined company.
- Review the transaction’s closing conditions, termination rights, related costs, and potential changes to the proposed structure.
- Evaluate Bakkt’s historical and projected financial performance, liquidity needs, capital structure, regulatory exposure, data-security risks, and internal controls using the detailed SEC filings.